Php171 - Revisiting Reimbursed Drugs With Alternative Payment Model in Turkey: 2016-2018

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1065
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Inflation and Balanced-Path Growth With Alternative Payment Mechanisms*

Economic Journal
EconomicsEconometrics
2004English

Pgi11 - High Levels of Reimbursed Cost and Use of Gastroenterological Drugs in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Payment Restrictions for Prescription Drugs Under Medicaid

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
1992English

Revisiting the Feldstein-Horioka Puzzle for Turkey

Journal of Applied Economics
EconomicsEconometricsFinance
2020English

Revisiting the Holographic Dark Energy in a Non-Flat Universe: Alternative Model and Cosmological Parameter Constraints

European Physical Journal C
EngineeringAstronomyPhysics
2014English

Revisiting the 2016 SWCS International Annual Conference

Journal of Soils and Water Conservation
Soil ScienceNatureCrop ScienceLandscape ConservationAgronomyTechnologyWater Science
2016English

Turkey Country Gender Assessment 2018

2018English

Succeeding With What You Wished For: Alternative Payment Models and Key Success Factors (P11)

Journal of Pain and Symptom Management
NeurologyAnesthesiologyPain MedicineNursing
2019English

Tuberculosis — Drugs in the 2016 Development Pipeline

Nature Reviews Disease Primers
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy